pill

The ex-wife of the Angels employee who gave pitcher Tyler Skaggs fentanyl-laced opioid pills was steadfast in her testimony Monday and Tuesday that Angels executives knew of her then-husband’s opioid abuse for several years before Skaggs died after chopping up and snorting the pills in 2019.

The testimony of Camela Kay directly contradicted that of the Angels then-vice president of communications, Tim Mead, and traveling secretary Tom Taylor, both of whom testified during the first week of a trial in Orange County Superior Court that is expected to last until December.

Skaggs’ widow, Carli, and his parents, Debbie Hetman and Darrell Skaggs, are the plaintiffs in the lawsuit against the Angels and are seeking $118 million in lost earnings, unspecified damages for pain and suffering plus punitive damages.

Camela Kay’s testimony fortified the Skaggs family’s contention that the Angels knew that Eric Kay — the team’s communications director of 23 years who is now serving a 22-year prison term for his role in Skaggs’ death — had serious drug problems and that his supervisors and co-workers did not follow team and Major League Baseball policies in dealing with the issues.

Leah Graham, another in the Skaggs family’s deep roster of accomplished attorneys, questioned Camela Kay, taking her through a timeline beginning in 2013 when she first recognized that her husband had a drug problem.

During an Angels road trip to New York to play the Yankees, Eric admitted to her, “I take five Vicodin a day,” Camela testified. She said he made the admission in front of Mead and Taylor, whom she described as shocked, and they told her they “were going to do whatever they could to help him.”

She continued to suspect illicit drug use, however, and the issues came to the forefront in 2017, when the Kay family staged in intervention at their home on Oct. 1, the day after the Angels’ season ended.

Camela testified about a phone call that day in which she said she told Taylor that Eric’s sister, Kelly Miller, had notified her that Eric was distributing pills to Skaggs. Camela said of Taylor’s reaction, “He blows me off.”

The next day, Mead and Taylor visited the Kay home to try to convince Eric to go to rehab for “opioid addiction,” according to Camela. He said Eric told Mead to go into his bedroom and find pills he had stashed there. Mead returned with a handful of baggies containing pills.

“I was standing afar, and Tom was on the couch with Eric, and all of a sudden I see Tim walk out of our bedroom with baggies of pills,” Camela Kay said.

She said Mead placed the pills on the coffee table in front of the couch where Eric Kay and Taylor were sitting. She testified that she believed her then-husband — their divorce was finalized in 2023 — was selling the baggies of opioids to players to make extra money because the family had financial difficulties.

Both Mead and Taylor denied in their testimony that they had any recollection of finding or seeing any baggies full of pills. Mead said he recalled “very little of that morning” and did not remember going into Eric Kay’s bedroom or finding pills there.

Camela Kay testified that she witnessed team employees and players handing out opioid pills on a team flight. On cross-examination, Angels lawyer Todd Theodora asked her how many team flights she had been on, and Camela answered 10 to 12.

Theodora also pointed out discrepancies in her testimony compared to what she said in her deposition several months ago. He also pointed out that in nearly 200 texts and emails to Angels personnel, she never warned them that her husband might be taking or distributing opioids.

Camela said she had strong suspicions throughout the 2018 season that Eric was still using because he displayed erratic behavior and noted that she shared those concerns with Taylor, whose office at Angel Stadium was adjacent to her husband’s.

The Angels have attempted to establish that Eric Kay was diagnosed with bipolar disorder, although Camela disputed that. When Theodora pressed her on her assertion that she had never heard her husband was bipolar, she replied, “He had a drug addiction.”

Camela testified that Eric told her that he was taking opioids to mask mental health issues that included depression, but that he was not taking prescribed medication for bipolar disorder.

A crisis occurred Easter Sunday — April 21, 2019 — when Eric was acting erratically at work and was hospitalized that evening after Taylor had driven him home. While taking Eric’s items from Taylor’s car, Camela said, she found an Advil bottle filled with blue pills next to the car and dumped them on the passenger seat to show Taylor.

Taylor testified that he while he did recall Eric acting erratically and driving him home, he didn’t recall the blue pills in the Advil bottle.

Although Camela said she was forceful in telling Mead and Taylor that Eric needed detox and inpatient care, instead he went through an outpatient rehab program in late April and May. He returned to work — by this time moving up to the position Mead had held before he departed that spring to become president of the Baseball Hall of Fame and Museum in Cooperstown, N.Y. — and about a month later was assigned to go on the trip to Texas that resulted in Skaggs’ death.

Angels communications employee Grace McNamee testified last week that when she learned Eric Kay was going on the trip, she asked colleague Adam Chodzko, “Is this a good idea?”

“Maybe I was talking out loud, the mother in me, it just felt like maybe Eric should spend some time at home after being on leave for, you know, bipolar and mental illness,” McNamee testified.

Testimony last week from Angels human resources executive Mayra Castro established that Eric Kay wasn’t fired, but instead was allowed to resign Nov. 2, 2019. Graham said this bolstered the Skaggs family’s contention that the Angels repeatedly gave Kay special treatment rather than treating his behavior the way they would with other employees.

Castro told Graham that a 63-year-old longtime Angels custodial worker was fired for drinking a hard seltzer during a break. The employee was not visibly intoxicated and told HR she was unaware the drink contained alcohol, Castro testified. The Skaggs family’s lawyers suggested that had Kay been punished similarly, Tyler Skaggs would still be alive.

Castro also admitted to deleting and then restoring an August 2019 text she sent to a co-worker that said of Kay, “Dude he gave me tweaker vibes.” The co-worker responded: “Omfg, I always thought he definitely looked like a tweaker and sketch.” Castro testified that she realized deleting the text was wrong and turned it over to the Skaggs family‘s legal team as part of discovery.

Emily Jansson, 34, was on a flight from Canada to Dubai for a girls’ trip when she suddenly began experiencing ‘weird chest pains’ and coughing fits

A terrifying mid-air medical emergency has been recounted by a woman who suffered a life-threatening blood clot in her lungs during a long-haul flight. Emily Jansson, a 34 year old mother of two, was on her way from Canada to Dubai International Airport for a getaway with friends on February 5, 2025.

However, the lengthy journey took a nearly fatal turn when she started to experience “weird chest pains” alongside uncontrollable coughing.

Jansson had just awoken after sleeping for a significant portion of the 13-hour flight and was waiting to use the bathroom when she lost consciousness and collapsed, remaining out for about five minutes. “I was waiting for the bathroom and I got this really deep, dull aching pain in my chest out of nowhere,” she recalls of the ordeal.

In the fall, Jansson sustained injuries as she knocked her head, resulting in a bruised eye and arm, and afterwards found herself grappling with confusion and fragmented memories.

READ MORE: Qatar Airways plane diverted back to UK after Iran opens fire on US baseREAD MORE: Jessie J gives ‘honest’ cancer surgery update as she shares hospital bed picture

Upon landing, which luckily occurred only two and a half hours later, she was swiftly taken to Rashid Hospital Dubai where urgent medical scans revealed a chilling diagnosis. A bilateral saddle pulmonary embolism.

This is an extensive blood clot situated within the primary artery of the lung which divides into branches for each lung.

The seriousness of her condition meant that any delay in treatment could have been catastrophic, reports the Mirror US. Doctors were astonished at her survival, admitting that given the circumstances, “it was essentially a miracle” she didn’t succumb to cardiac arrest.

In hindsight, Jansson identified multiple risk factors that contributed to her in-flight emergency. These included prolonged immobility despite wearing compression stockings, and the estrogen birth control pill Zamine, both posing substantial threats to her wellbeing during the flight.

This combined contraceptive pill, containing both progestogen and estrogen, can increase the likelihood of blood clots. She is currently on anticoagulant medication to prevent further clotting and will remain on this treatment for a minimum of six months.

She explained: “I was restricting my body’s blood flow, which contributed to my clot developing. I had little idea about the danger I was in. After taking estrogen birth control for six years before consistently, I didn’t know my risk of blood clots was so high.”

A saddle pulmonary embolism, a condition where a blood clot obstructs the artery feeding the lungs, only represents 2 to 5 per cent of all pulmonary embolism cases. If not addressed promptly, it can result in heart failure and cause sudden death in approximately 30 per cent of instances.

“I was terrified and partly in denial when they told me what I had. I knew someone who had the same thing and how serious it was and I was just freaking out,” Jannson admitted.

Jannson spent six days in hospital receiving thrombolytic therapy and clot-dissolving medication. She recuperated with a friend in Dubai for three weeks post-treatment.

“It’s important that people know about the risks of this particular birth control, Zamine, and the safety of flying. If you’re on a long-haul flight, make sure you move around and let your body breathe,” she cautioned.

Jannson elaborated: “I was fortunate that there was a doctor on board and some very amazing, competent flight attendants. They essentially saved my life when it shouldn’t have been possible.

“I’m still recovering from this episode, and my body has been through a lot. But I’m hopeful my experience can educate people about the risks of blood clots. And just as a reminder that life is so precious and to just really appreciate it.”

California and three other states petitioned the U.S. Food and Drug Administration Thursday to ease its new restrictions on the abortion pill mifepristone, citing the drug’s proven safety record and arguing the new limits are unnecessary.

“The medication is a lifeline for millions of women who need access to time-sensitive, critical healthcare — especially low-income women and those who live in rural and underserved areas,” said California Atty. Gen. Rob Bonta, who filed the petition alongside the attorneys general of Massachusetts, New York and New Jersey.

The petition cites Senate testimony by Health and Human Services Secretary Robert F. Kennedy Jr. last month, in which Kennedy said he had ordered FDA administrator Martin Makary to conduct a “complete review” of mifepristone and its labeling requirements.

The drug, which can be received by mail, has been on the U.S. market for 25 years and taken safely by millions of Americans, according to experts. It is the most common method of terminating a pregnancy in the U.S., with its use surging after the Supreme Court overturned Roe vs. Wade in 2022.

The Supreme Court upheld access to the drug for early pregnancies under previous FDA regulations last year, but it has remained a target of anti-abortion conservatives. The Trump administration has given Kennedy broad rein to shake up American medicine under his “Make America Healthy Again” banner, and Kennedy has swiftly rankled medical experts by using dubious science — and even fake citations — to question vaccine regimens and research and other longstanding public health measures.

At the Senate hearing, Kennedy cited “new data” from a flawed report pushed by anti-abortion groups — and not published in any peer-reviewed journal — to question the safety of mifepristone, calling the report “alarming.”

“Clearly, it indicates that, at very least, the label should be changed,” Kennedy said.

Sen. Josh Hawley (R-Mo.) on Monday posted a letter from Makary to X, in which Makary wrote that he was “committed to conducting a review of mifepristone” alongside “the professional career scientists” at the FDA.

Makary said he could not provide additional information given ongoing litigation around the drug.

The states, in their 54-page petition, wrote that “no new scientific data has emerged since the FDA’s last regulatory actions that would alter the conclusion that mifepristone remains exceptionally safe and effective,” and that studies “that have frequently been cited to undermine mifepristone’s extensive safety record have been widely criticized, retracted, or both.”

Democrats have derided Kennedy’s efforts to reclassify mifepristone as politically motivated and baseless.

“This is yet another attack on women’s reproductive freedom and scientifically-reviewed health care,” Gov. Gavin Newsom said the day after Kennedy’s Senate testimony. “California will continue to protect every person’s right to make their own medical decisions and help ensure that Mifepristone is available to those who need it.”

Bonta said Thursday that mifepristone’s placement under the FDA’s Risk Evaluation and Mitigation Strategy program for drugs with known, serious side effects — or REMS — was “medically unjustified,” unduly burdened patient access and placed “undue strain on the nation’s entire health system.”

He said mifepristone “allows people to get reproductive care as early as possible when it is safest, least expensive, and least invasive,” is “so safe that it presents lower risks of serious complications than taking Tylenol,” and that its long safety record “is backed by science and cannot be erased at the whim of the Trump Administration.”

The FDA has previously said that fewer than 0.5% of women who take the drug experience “serious adverse reactions,” and deaths are exceedingly rare.

The REMS program requires prescribers to add their names to national and local abortion provider lists, which can be a deterrent for doctors given safety threats, and pharmacies to comply with complex tracking, shipping and reporting requirements, which can be a deterrent to carrying the drug, Bonta said.

It also requires patients to sign forms in which they attest to wanting to “end [their] pregnancy,” which Bonta said can be a deterrent for women using the drug after a miscarriage — one of its common uses — or for those in states pursuing criminal penalties for women seeking certain abortion care.

Under federal law, REMS requirements must address a specific risk posed by a drug and cannot be “unduly burdensome” on patients, and the new application to mifepristone “fails to meet that standard,” Bonta said.

The states’ petition is not a lawsuit, but a regulatory request for the FDA to reverse course, the states said.

If the FDA will not do so nationwide, the four petitioning states asked that it “exercise its discretion to not enforce the requirements” in their states, which Bonta’s office said already have “robust state laws that ensure safe prescribing, rigorous informed consent, and professional accountability.”